CACI vs ZBRA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CACI exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. While the current price of $516.54 is significantly above the defensive Graham Number ($313.75), it trades at a substantial discount to its growth-based intrinsic value of $688.83 and analyst targets. Despite bearish short-term technicals and insider selling, the company's consistent track record of earnings beats and double-digit EPS growth support a long-term bullish outlook.
ZBRA exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and no Altman Z-Score provided. The stock is currently trading at a significant premium to its Graham Number ($115.46) and Intrinsic Value ($57.33), suggesting a high valuation relative to current fundamentals. While the PEG ratio (0.49) and Forward P/E (11.29) indicate strong future growth expectations, these are contrasted by a severe current earnings contraction of -55.8% and bearish technical trends. Liquidity is a primary concern, evidenced by a Quick Ratio of 0.52.
Compare Another Pair
Related Comparisons
CACI vs ZBRA: Head-to-Head Comparison
This page compares CACI International Inc (CACI) and Zebra Technologies Corporation (ZBRA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.